DavidECohnMDMBA FACHE

Gynecologic Oncology

Interim Chief Executive Officer Chief Medical Officer, Arthur G. James Cancer Hospital Director, Division of Gynecologic Oncology Professor, Department of Obstetrics and Gynecology Ohio State University College of Medicine

Join to view full profile

Dr. Cohn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Cohn's full profile

Already have an account?

Office
1145 Olentangy River Rd
Columbus, OH 43212
Phone+1 614-293-3873

Fax+1 614-293-3078

Education & Training

Ohio State University Fisher College of BusinessMBA, 2018 - 2020
Washington University/B-JH/SLCH ConsortiumFellowship, Gynecologic Oncology, 1998 - 2001
University of WashingtonResidency, Obstetrics and Gynecology, 1994 - 1998
Georgetown University School of MedicineClass of 1994

Certifications & Licensure

OH State Medical License 2001 - 2027
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
American College of Healthcare ExecutivesFACHE

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2005 Jan 01
Completed
Phase 2
Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinum Chemotherapy Start of enrollment: 2008 Apr 01
Completed
Phase 1
Steep Trendelenburg Positioning on Intra-Ocular Pressure During Surgery for Endometrial Robotics Versus Laparotomy Start of enrollment: 2009 May 01
Withdrawn
Study of Post Operative Pain in Endometrial Cancer Robotic Versus Laparotomy Start of enrollment: 2009 Apr 08
Completed
Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 06
Completed
Phase 2
Effects of Steep Trendelenburg Positioning on Intro-ocular Pressure During Surgery for Endometrial Cancer - Robotics Versus Laparotomy Start of enrollment: 2010 Jun 01
Join now to see all

Publications & Presentations

PubMed

Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings.
Paulina J Haight, Ashwini Esnakula, Courtney J Riedinger, Adrian A Suarez, Jessica Gillespie
NPJ Precision Oncology. 2025-02-08
Randomized phase II study of bevacizumab with weekly anetumab ravtansine or weekly paclitaxel in platinum-resistant/refractory high grade ovarian cancer (NCI trial).
Husam A Alqaisi, David E Cohn, Jing-Yi Chern, Linda R Duska, Andrea Jewell
Clinical Cancer Research. 2025-01-21
Changes in anthropometry, adiposity, and inflammation in Black and White women engaged in intentional weight loss.
Ashley S Felix, Jennifer A Sinnott, Bette J Caan, Shannon L Gillespie, Caitlin E Meade
Obesity. 2024-12-01

Journal Articles

Endometrial Carcinoma Recurrence According to Race and Ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study
M L Pearl, D S Miller, W T Creasman, P H Thaker, J F Boggess, S R Guntupalli, D G Mutch, J L Walker, O B Ioffe, D E Cohn, L S Downs, International Journal of Cancer

Press Mentions

Ohio State James Cancer Hospital Partners with Columbus Community Oncology PracticeDecember 16th, 2024
Should I Get the COVID-19 Booster?September 17th, 2021
Dublin Cancer Survivor Reacts to CDC's Recommendation for Third COVID-19 Vaccine DoseAugust 13th, 2021
Join now to see all